ℹ️
🇬🇧
Search
Search for publications relevant for "Cellular immunotherapy"
Cellular immunotherapy
Publication
Class
Person
Publication
Programmes
publication
Thapsigargin-stimulated lad2 human mast cell line is a potent cellular adjuvant for the maturation of monocyte-derived dendritic cells for adoptive cellular immunotherapy
2021 |
Second Faculty of Medicine
publication
Adoptive cellular immunotherapy with targeted drugs
2000 |
First Faculty of Medicine
publication
Active cellular immunotherapy of ovarian cancer using dendritic cells
2012 |
Second Faculty of Medicine
publication
LL-37 as a Powerful Molecular Tool for Boosting the Performance of Ex Vivo-Produced Human Dendritic Cells for Cancer Immunotherapy
2022 |
Second Faculty of Medicine
publication
Phase I/II trial of dendritic cell-based active cellular immunotherapy with DCVAC/PCa in patients with rising PSA after primary prostatectomy or salvage radiotherapy for the treatment of prostate cancer
2018 |
Second Faculty of Medicine, First Faculty of Medicine
publication
Autologous dendritic cell-based immunotherapy (DCVAC/LuCa) and carboplatin/paclitaxel in advanced non-small cell lung cancer: A randomized, open-label, phase I/II trial
2021 |
First Faculty of Medicine, Central Library of Charles University, Faculty of Medicine in Pilsen
publication
Report of University Hospital Hradec Králové to the clinical trial protocol No: SP001
Publication without faculty affiliation
publication
Current Approaches in Cancer Immunotherapy
2015 |
First Faculty of Medicine
publication
Lactate from the tumor microenvironment - A key obstacle in NK cell-based immunotherapies
2022 |
Central Library of Charles University, Faculty of Science
publication
Trial Watch Dendritic cell-based interventions for cancer therapy
2013 |
Second Faculty of Medicine
publication
High hydrostatic pressure affects antigenic pool in tumor cells: Implication for dendritic cell-based cancer immunotherapy
2017 |
Second Faculty of Medicine
publication
SARS-CoV-2 spike glycoprotein-reactive T cells can be readily expanded from COVID-19 vaccinated donors
2021 |
Second Faculty of Medicine
publication
Generation of dendritic cell-based vaccine using high hydrostatic pressure for non-small cell lung cancer immunotherapy
2017 |
Second Faculty of Medicine, First Faculty of Medicine
publication
Detection of tumor antigens and tumor-antigen specific T cells in NSCLC patients: Correlation of the quality of T cell responses with NSCLC subtype
2020 |
Second Faculty of Medicine, First Faculty of Medicine
publication
Dendritic cell-based immunotherapy (DCVAC/OvCa) combined with second-line chemotherapy in platinum-sensitive ovarian cancer (SOV02): A randomized, open-label, phase 2 trial
2021 |
First Faculty of Medicine, Central Library of Charles University, Third Faculty of Medicine
publication
Efficacy and Safety of Autologous Dendritic Cell-Based Immunotherapy, Docetaxel, and Prednisone vs Placebo in Patients With Metastatic Castration-Resistant Prostate Cancer The VIABLE Phase 3 Randomized Clinical Trial
2022 |
Faculty of Medicine in Hradec Králové